Our 2-day event will take place in 2025 in Pennsylvania, a thriving hub of innovation. We are aiming to bring 2000 global executives, 300 speakers and 100 sponsors.


The agenda covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data.

 

BioTechX Tracks

 

AI IN DRUG DISCOVERY AND DEVELOPMENT
Advances in AI for drug development
AI in clinical trials
Limitations of AI in drug development
Data expansion in AI
 
LLMs
 
Applications of LLMs in Drug Development
Clinical Research
Practical application of LLMs
Cost effective ways to enable AI
Language models in Pharma
PRECISION MEDICINE AND LIQUID BIOPSY
Manufacturing CAR T cells
Immuno-oncology
Multi-cancer early detection
Personalised medicine for drug safety
 
BIG DATA IN ONCOLOGY
 
Clinical biomarkers
Tumour microenvironment
Translational data sources
Analytical and regulatory challenges
Oncology drug development
DATA MANAGEMENT, STORAGE AND ARCHITECHTURE 
Data platforms 
FAIR architectures 
Enterprise data 
Electronic lab notebook 

 

ANALYTICS PLATFORM
 
Data privacy 
AI/ML driving clinical outcomes 
Industrialising AI 
Analytics paradigm

 

DATA INTEGRATION + FAIR
 
Research and development
Language models
Silo busting
Pre and post acquisition
 
BIOINFORMATICS + INSILICO R&D
 
Clinical development
Data driven drug discovery
Global biologics informatics platforms
Multi omics
 
DIGITAL TRANSFORMATION
 
Digital health solutions
Applications in the life science industry
Drug development efficiency
Inclusive data management
 
REAL WORLD EVIDENCE
 
Real world data
Future applications
Leveraging AI for RWE
Real world evidence in the clinical setting
 
AI in Clinical Trials
 
Enhancing patient recruitment with AI algorithms
AI-driven trial design and optimization
Predictive analytics for clinical outcomes
Accelerating drug development through machine learning
 
 
BIOMARKERS + COMPANION DIAGNOSTICS
Image based machine learning models
Single molecule detection
Digital biomarkers
Multi-cancer early detection
 
RARE DISEASE IN GENOMICS
 
In-vivo gene editing
Accelerating medicines for rare diseases
Neurodevelopmental disorders
Future of rare diseases
 

Get involved at BioTechX USA

 

 

TO SPONSOR


Joshua Kennedy
joshua.kennedy@terrapinn.com

 

TO SPEAK


Anna Abiola
anna.abiola@terrapinn.com

 

MARKETING OPPORTUNITIES


Karen Duncan
karen.duncan@terrapinn.com